Skip to main content
. 2022 Oct 23;8(3):101058. doi: 10.1016/j.adro.2022.101058

Table 3.

Management of symptomatic versus asymptomatic brain metastases

Treatment Overall, n (%) Asymptomatic, n (%) Symptomatic, n (%) P value
No treatment 39 (18.3) 0 (0) 4 (11.4) 1
Steroids 32 (82.1) 0 (0) 32 (91.4) <.001
Prior immunotherapy 10 (25.6) 0 (0) 10 (28.6) .56
Active immunotherapy 3 (7.7) 0 (0) 3 (8.6) 1
Stereotactic radiosurgery alone 18 (46.2) 4 (100) 14 (40.0) .04
Surgery 9 (35.3) 0 (0) 9 (25.7) .56
Hospitalization for brain met 23 (59.0) 0 (0) 23 (65.7) .02
Whole brain radiation therapy 8 (20.5) 0 (0) 8 (22.9) .56